AITA, ADA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.296
EU - Europa 2.638
AS - Asia 2.193
AF - Africa 554
SA - Sud America 524
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 29
Totale 10.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.993
IT - Italia 1.301
SG - Singapore 803
CN - Cina 434
BR - Brasile 356
HK - Hong Kong 262
PL - Polonia 149
DE - Germania 128
NL - Olanda 123
VN - Vietnam 109
FI - Finlandia 105
SE - Svezia 104
RU - Federazione Russa 91
GB - Regno Unito 78
FR - Francia 67
IN - India 46
IE - Irlanda 44
CA - Canada 36
ES - Italia 36
CI - Costa d'Avorio 35
MX - Messico 34
AR - Argentina 31
BJ - Benin 31
KR - Corea 28
ZA - Sudafrica 28
ID - Indonesia 27
MA - Marocco 26
GR - Grecia 25
JP - Giappone 25
JO - Giordania 24
TR - Turchia 24
AT - Austria 23
PH - Filippine 22
UA - Ucraina 22
DZ - Algeria 21
MK - Macedonia 21
AE - Emirati Arabi Uniti 20
IQ - Iraq 20
RO - Romania 20
KZ - Kazakistan 19
PR - Porto Rico 19
AD - Andorra 18
BA - Bosnia-Erzegovina 18
CO - Colombia 18
EC - Ecuador 18
GN - Guinea 18
HR - Croazia 18
IL - Israele 18
PY - Paraguay 18
UZ - Uzbekistan 18
YE - Yemen 18
BB - Barbados 17
BW - Botswana 17
CL - Cile 17
CR - Costa Rica 17
CW - ???statistics.table.value.countryCode.CW??? 17
GA - Gabon 17
GF - Guiana Francese 17
GT - Guatemala 17
ME - Montenegro 17
NP - Nepal 17
PS - Palestinian Territory 17
YT - Mayotte 17
AZ - Azerbaigian 16
BY - Bielorussia 16
LV - Lettonia 16
MR - Mauritania 16
NI - Nicaragua 16
RE - Reunion 16
SN - Senegal 16
TN - Tunisia 16
VE - Venezuela 16
AO - Angola 15
DK - Danimarca 15
GM - Gambi 15
KG - Kirghizistan 15
MY - Malesia 15
PT - Portogallo 15
TW - Taiwan 15
AL - Albania 14
BF - Burkina Faso 14
GE - Georgia 14
HU - Ungheria 14
JM - Giamaica 14
LA - Repubblica Popolare Democratica del Laos 14
MN - Mongolia 14
TT - Trinidad e Tobago 14
CD - Congo 13
CH - Svizzera 13
CY - Cipro 13
LB - Libano 13
LY - Libia 13
MU - Mauritius 13
PE - Perù 13
SI - Slovenia 13
TJ - Tagikistan 13
BS - Bahamas 12
CU - Cuba 12
CZ - Repubblica Ceca 12
DO - Repubblica Dominicana 12
Totale 9.720
Salva come PNG Salva come JPEG
Città #
Fairfield 514
Ashburn 483
Singapore 452
Woodbridge 379
Ann Arbor 282
Houston 257
Hong Kong 248
Chandler 234
Cambridge 196
Seattle 167
Wilmington 155
Bytom 128
Boardman 105
Padova 104
Beijing 101
Milan 101
Santa Clara 83
Los Angeles 69
Rome 60
Medford 58
Princeton 58
São Paulo 54
Des Moines 48
San Diego 48
Dublin 39
Helsinki 39
Nanjing 38
Ho Chi Minh City 37
Abidjan 35
Munich 35
Roxbury 34
Florence 31
Trento 31
Cotonou 29
Bologna 26
Hefei 24
Turku 24
Amman 23
Buffalo 23
New York 23
Jinan 22
Naples 20
Redondo Beach 20
Chicago 19
Conakry 18
Dallas 18
Hanoi 18
Andorra la Vella 17
Bridgetown 17
Shenyang 17
Baku 16
Dakar 16
Nouakchott 16
Johannesburg 15
Libreville 15
Managua 15
San José 15
Sanaa 15
Tashkent 15
Hebei 14
Nuremberg 14
Dong Ket 13
Gaborone 13
Genoa 13
London 13
Nanchang 13
Ouagadougou 13
Riga 13
Skopje 13
Venezia 13
Vienna 13
Dushanbe 12
Guangzhou 12
Havana 12
Kampala 12
Nassau 12
Noumea 12
Podgorica 12
Ulan Bator 12
Vientiane 12
Warsaw 12
Zagreb 12
Bishkek 11
Boston 11
Castries 11
Chennai 11
Harare 11
Pieve a Nievole 11
Athens 10
Brooklyn 10
Cayenne 10
Copenhagen 10
Kigali 10
Kingston 10
Kinshasa 10
Lusaka 10
Mexico City 10
Seoul 10
Taizhou 10
Vicenza 10
Totale 5.675
Salva come PNG Salva come JPEG
Nome #
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 512
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 505
Genetics in TNF-TNFR pathway: a complex network causing spondyloarthritis and conditioning response to therapy 327
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 225
An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes 221
Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies 212
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 211
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 206
Performance criteria and quality indicators for the post-analytical phase 205
Quality indicators to detect pre-analytical errors in laboratory testing 186
Harmonization of pre-analytical quality indicators. 177
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 171
What information on measurement uncertainty should be communicated to clinicians, and how? 171
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 168
Decision Support and Patient Safety 166
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 164
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 161
Performance criteria and quality indicators for the pre-analytical phase. 159
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 157
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 151
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave 150
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis 149
A Lys49-PLA2 Myotoxin of Bothrops asper triggers a rapid death of macrophages that involves autocrine purinergic receptor signalling 148
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 147
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 144
The circulating miRNAs as diagnostic and prognostic markers 140
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 137
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 136
Hyris bCUBE SARS-CoV-2 rapid molecular saliva testing: a POCT innovation on its way 136
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms 135
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 128
Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach 128
The silk road to total quality in Laboratory Medicine 128
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 127
Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study 125
Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: Innate immunity, taste perception and FABP5 proteins make the difference 123
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 118
Micro-rnas as potential diagnostic and prognostic biomarkers in pancreatic cancer: Methodological choices and issues 118
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 117
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 116
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 116
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 114
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 113
Extra-analytical quality indicators and laboratory performances 112
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 111
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 111
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 109
Serum mirna profiling for early pdac diagnosis and prognosis: A retrospective study 109
Colorectal cancer and inflammatory bowel diseases share common salivary proteomic pathways 109
Ketogenic diet improves disease activity and cardiovascular risk in psoriatic arthritis: A proof of concept study 108
New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance 107
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 107
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 103
Extra-analytical quality indicators - Where to now? 98
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 96
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 95
Check-list in laboratory medicine: An important tool to improve patient safety. The blood collection 95
Polimorfismi dei geni KLK3, RASA1 e NAALADL2: rischio di cancro alla prostata, aggressività della neoplasia e livelli sierici dell’Antigene Prostatico-Specifico 94
Quality Indicators for the Total Testing Process 93
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 92
Wrong blood in tube: a SIBioC project for a persistent problem 91
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 91
Salivary alpha-amylase: A marker of stress in gynecological residents during a shoulder dystocia simulation scenario 89
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 87
IFCC project “Model of quality indicators”: a method for results evaluation 86
Plasma lipids paediatric reference intervals: Indirect estimation using a large 14-year database 80
Quality indicators to monitor the rejected outpatients' samples 80
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 77
Patient Safety in Laboratory Medicine 74
Impatto dell’emergenza COVID-19 nei laboratori: esperienze e opinioni dei SIBioC Young Scientists 65
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 65
La medicina di laboratorio: Gli Specialisti di domani 63
Erratum: Performance criteria and quality indicators for the pre-analytical phase (Clinical Chemistry and Laboratory Medicine (2015) 53: 6 (943-948) DOI: 10.1515/cclm-2014-1124) 60
Patient safety and clinical risk in the clinical laboratory haematological process 57
Tecnologia, competenza e collaborazione con i clinici sono elementi chiave per la diagnosi di cistinuria 56
Harmonization of quality indicators in Laboratory Medicine 43
Misidentification in laboratory medicine: Results of the Tuscany survey of the Clinical Risk Management Study Group SIBioC and the Italian Society of Ergonomy (SIE) 39
Totale 10.400
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.518
article - articoli 21.645
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 206
Totale 52.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 39 14 25 29 96 90 77 90
2021/2022821 28 142 83 15 13 73 59 69 43 41 92 163
2022/2023713 125 43 29 45 128 75 27 55 104 25 39 18
2023/2024683 34 34 58 52 40 44 127 51 48 49 69 77
2024/20252.117 41 110 98 113 234 57 131 164 188 93 343 545
2025/20263.508 476 637 1.011 1.121 263 0 0 0 0 0 0 0
Totale 10.400